Kinnate Biopharma Inc. (KNTE)

NASDAQ: KNTE · Real-Time Price · USD

2.65

-0.01 (-0.38%)

At close: Apr 02, 2024, 8:00 PM

Kinnate Biopharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q4 2019
Period Ending	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Dec 31, 2019
Cash & Equivalents	57M	51.66M	34.51M	73.57M	29.26M	34.5M	35.06M	33.1M	116.1M	135.01M	132.99M	182.39M	365.46M	156.86M	76.45M
Short-Term Investments	97.04M	115.91M	150.2M	127.41M	172.21M	196.48M	197.93M	206.16M	103.36M	88.22M	87.02M	65.81M	31.4M	n/a	n/a
Long-Term Investments	10.63M	12.76M	19.58M	30.2M	39.14M	31.1M	46.6M	63.13M	105.45M	124.64M	145.14M	134.91M	n/a	n/a	n/a
Other Long-Term Assets	38K	2.52M	2.33M	2.34M	2.4M	3.11M	3.09M	3.1M	1.77M	690K	461K	n/a	n/a	1.4M	n/a
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	973K
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-973K	n/a	n/a
Other Current Assets	4.14M	2.73M	3.9M	4.31M	3.64M	3.73M	34.14M	4.93M	5.64M	3.18M	38.77M	2.98M	3.34M	620K	25K
Total Current Assets	158.18M	170.3M	188.6M	205.29M	230.84M	261.18M	267.13M	275.2M	258.69M	260.71M	258.78M	251.17M	400.2M	157.48M	77.45M
Property-Plant & Equipment	4.76M	5.13M	5.63M	6.05M	6.45M	6.75M	7.07M	7.19M	956K	291K	286K	283K	368K	316K	154K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	15.43M	20.41M	27.54M	38.59M	47.99M	40.96M	56.76M	73.42M	108.17M	125.62M	145.88M	135.19M	368K	1.72M	154K
Total Assets	173.6M	190.71M	216.13M	243.88M	278.83M	302.13M	323.9M	348.62M	366.86M	386.33M	404.66M	386.37M	400.57M	159.2M	77.61M
Account Payables	2.03M	2.93M	2.7M	4.45M	2.97M	3.06M	2.02M	4.42M	3.15M	2.72M	1.33M	3.21M	3.94M	2.33M	956K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	892K	869K	959K	983K	991K	966K	836K	454K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	9.07M	11.98M	12.12M	12.72M	13.21M	11.32M	8.61M	8.78M	9.24M	7.58M	6.99M	4.58M	3.36M	4.37M	989K
Total Current Liabilities	11.99M	15.77M	15.77M	18.16M	17.17M	15.34M	11.46M	13.66M	12.39M	10.3M	8.32M	7.79M	7.3M	6.7M	1.95M
Long-Term Debt	2.28M	2.52M	2.74M	2.96M	3.19M	3.45M	3.7M	4.14M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	93.15M
Total Long-Term Liabilities	2.28M	2.52M	2.74M	2.96M	3.19M	3.45M	3.7M	4.14M	35M	35M	35M	n/a	n/a	n/a	93.15M
Total Liabilities	14.28M	18.29M	18.52M	21.12M	20.36M	18.79M	15.17M	17.8M	12.39M	10.3M	8.32M	7.79M	7.3M	6.7M	95.09M
Total Debt	3.17M	3.38M	3.7M	3.95M	4.18M	4.42M	4.54M	4.6M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock	5K	5K	5K	5K	4K	4K	4K	4K	4K	4K	4K	4K	4K	3K	n/a
Retained Earnings	-372.01M	-354.95M	-324.22M	-292.3M	-259.36M	-227.8M	-197.06M	-169.99M	-143.09M	-116.93M	-92.23M	-70.79M	-53.33M	-39.62M	-17.57M
Comprehensive Income	-12K	-147K	-342K	-464K	-1.41M	-2.56M	-2.74M	-2.18M	-524K	-36K	-74K	-40K	-9K	n/a	n/a
Shareholders Equity	159.33M	172.42M	197.62M	222.76M	223.47M	248.34M	273.73M	295.82M	319.48M	341.03M	361.34M	378.57M	393.27M	152.5M	-17.49M
Total Investments	107.67M	128.68M	169.78M	157.61M	211.35M	227.57M	244.53M	269.3M	208.81M	212.85M	232.15M	200.72M	31.4M	n/a	n/a